HIV Prevention for Black/African American Women: Calling Attention to PrEP

HIV Prevention for Black/African American Women: Calling Attention to PrEP

Continue to Course
Online Course | Specialties: Family Medicine, Internal Medicine, Primary Care
Released: 10/20/2021
Expires: 10/19/2022
Max Credits: 0.75
Continue to Course Read Abstract

Oni Blackstock, MD, MHS 
Founder and Executive Director 
Health Justice 
New York, NY 
Jenell S. Coleman, MD, MPH, FACOG 
Dr. John G. Griffith Associate Professor  
Division Director, Gynecologic Specialties 
Medical Director, JHOC Women’s Health Center 
Director, JHOC Resident Continuity Clinic 
Co-Director, JHOC Colposcopy Clinic 
Department of Gynecology and Obstetrics 
Johns Hopkins University School of Medicine 
Baltimore, MD
Samantha Hill, MD, MPH 
Assistant Professor 
Department of Pediatrics, Division of Adolescent Medicine 
The University of Alabama at Birmingham 
Birmingham, AL 

Activity Planners
Christie Avraamides, PhD
Senior Clinical Content Manager
Baltimore, MD
Samantha Gordon, MS
Accreditation Manager
Baltimore, MD
Amy Sison
Director of CME
Baltimore, MD
Kathryn Schaefer, MSN, RN, CPHRM, CHCP
Associate Director, Education Quality and Compliance
East Lansing, MI

Learning Objectives
Upon completion, participants should be able to:

  • Integrate HIV prevention into the routine care of Black/African American women using a nonjudgmental, sex-positive approach 
  • Identify factors that contribute to HIV risk among Black/African American heterosexual women
  • Recognize and address misconceptions about PrEP use in Black/African American heterosexual women

Target Audience
This activity is intended for primary care physicians, obstetrician-gynecologists, nurse practitioners, physician assistants, and nurses.
Statement of Need
Although Black/African American women constitute 13% of the female population in the United States, they account for approximately 60% of new HIV infections among women. A strategy to prevent new HIV transmission includes pre-exposure prophylaxis (PrEP). However, low PrEP uptake has been observed among Black/African American women despite their increased risk of acquiring HIV. Notably, both patient- and clinician-related factors contribute to this low PrEP uptake. Clinician-related factors include limited knowledge about PrEP implementation and lack of awareness regarding HIV risk factors among Black/African American women. Patient-related factors include lack of awareness regarding PrEP, having a low perceived risk of HIV, or being uncomfortable discussing HIV risk and sexual health with healthcare providers. This activity discusses best practices for HIV prevention in Black/African American heterosexual women, including the importance of and approaches for having respectful and sex-positive discussions about their HIV risk.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Med-IQ is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This nursing activity has been approved for up to 0.75 contact hour.

Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Instructions to Receive Credit
To receive credit, read the introductory CE material, watch the webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: October 20, 2021
Expiration Date: October 19, 2022
Estimated Time to Complete This Activity: 45 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 24 months that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Drug/Product Usage by Faculty
Off-label/unapproved drug uses or products are mentioned within this activity.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 
Oni Blackstock, MD, MHS 
Consulting fees/advisory boards: ClinicalMind

Jenell S. Coleman, MD, MPH, FACOG 
Contracted research: Gilead Sciences, Inc.

Samantha Hill, MD, MPH, has indicated no real or apparent conflicts. 

The peer reviewers and activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, Med-IQ has a policy to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
Contact Information
For CME/CE questions or comments about this activity, please contact the National Lipid Association. Call 904 998 0854 or email

System Requirements



  • Operating system - Med-IQ supports the current operating system, plus two prior releases:
    • Android (eg, Samsung Galaxy)
    • Apple (eg, iPhone/iPad)
  • Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
    • Android (Chrome)
    • Apple (Safari)

Applications & Software

For technical assistance, please refer to our Support Manual.

The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy policy, please visit:

Complimentary CE
This activity is available free of charge to participants.

Acknowledgment of Commercial Support
This activity is supported by an educational grant from Gilead Sciences, Inc.


Here are the key takeaways from this activity. Deeper insights and evidence, plus an opportunity to receive credit, are available at the "Continue" button below.

  • The lifetime risk of receiving an HIV diagnosis in the US is 1 in 54 for Black/African American women, 1 in 256 for Hispanic women/Latinas, and 1 in 941 for White women1
  • Black/African American women are more likely than White women to acquire HIV through heterosexual contact2
  • Factors that affect women’s HIV risk include socioeconomic challenges (eg, lack of access to healthcare, poverty), environment (eg, higher HIV prevalence among African American communities compared with other racial/ethnic groups, which increases risk exposure during sexual encounters), behaviors (eg, not knowing a partner’s HIV risk), and higher prevalence of STIs in African American individuals compared with other racial/ethnic groups3,4
  • PrEP is a user-controlled HIV prevention method; PrEP is indicated for women who are HIV negative and have a history of inconsistent or no condom use with sexual partner(s), had a bacterial STI in the past 6 months, or live in a high-prevalence area or sexual network5,6
  • Daily adherence is critical to PrEP effectiveness5,6

View reference list.

Click “Continue” to proceed through this activity and/or receive credit.

By clicking "Continue," you confirm that you have reviewed the CME information.


Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

COPYRIGHTED. Republication or redistribution of Med‑IQ content, including by framing, is prohibited without prior written consent. Med‑IQ shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.